Charles Schwab Investment Management Inc Intercept Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$9.99 - $18.71 $491,118 - $919,802	-49,161 Reduced 30.94%	109,717 $2.03 Million
Q2 2023 Aug 09, 2023	SELL	$9.17 - $19.29 $1.61 Million - $3.38 Million	-175,291 Reduced 52.46%	158,878 $1.76 Million
Q1 2023 May 11, 2023	BUY	$12.53 - $21.71 $707,456 - $1.23 Million	56,461 Added 20.33%	334,169 $4.49 Million
Q4 2022 Feb 13, 2023	BUY	$11.61 - $16.11 $1.34 Million - $1.86 Million	115,573 Added 71.28%	277,708 $3.44 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $2,625 - $4,235	215 Added 0.13%	162,135 $2.26 Million
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $179,006 - $312,264	-15,940 Reduced 8.96%	161,920 $2.24 Million
Q1 2022 May 13, 2022	BUY	$13.37 - $17.79 $1.5 Million - $2 Million	112,541 Added 172.29%	177,860 $2.89 Million
Q4 2021 Feb 11, 2022	SELL	$14.28 - $19.53 $69,857 - $95,540	-4,892 Reduced 6.97%	65,319 $1.07 Million
Q3 2021 Nov 16, 2021	SELL	$12.99 - $20.47 $1.51 Million - $2.38 Million	-116,382 Reduced 62.37%	70,211 $1.04 Million
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $147,689 - $234,048	9,553 Added 5.4%	186,593 $3.73 Million
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $496,027 - $968,702	-25,661 Reduced 12.66%	177,040 $4.09 Million
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $39,926 - $69,268	1,631 Added 0.81%	202,701 $5.01 Million
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $110,741 - $151,395	-2,833 Reduced 1.39%	201,070 $8.34 Million
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $1.69 Million - $3.32 Million	36,086 Added 21.5%	203,903 $9.77 Million
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $193,690 - $475,432	4,006 Added 2.45%	167,817 $10.6 Million
Q4 2019 Feb 07, 2020	BUY	$57.36 - $124.1 $179,250 - $387,812	3,125 Added 1.94%	163,811 $20.3 Million
Q3 2019 Nov 08, 2019	BUY	$58.69 - $80.46 $604,565 - $828,818	10,301 Added 6.85%	160,686 $10.7 Million
Q2 2019 Aug 09, 2019	BUY	$77.77 - $120.68 $1.37 Million - $2.13 Million	17,609 Added 13.26%	150,385 $12 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $1.13 Million - $1.49 Million	12,317 Added 10.23%	132,776 $14.9 Million
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $30,970 - $45,652	-361 Reduced 0.3%	120,459 $12.1 Million
Q3 2018 Nov 13, 2018	BUY	$88.49 - $127.55 $886,227 - $1.28 Million	10,015 Added 9.04%	120,820 $15.3 Million
Q2 2018 Aug 08, 2018	BUY	$60.0 - $85.67 $3.39 Million - $4.85 Million	56,556 Added 104.25%	110,805 $9.3 Million
Q1 2018 May 07, 2018	BUY	$52.72 - $67.25 $446,591 - $569,674	8,471 Added 18.5%	54,249 $3.34 Million
Q4 2017 Jan 17, 2018	SELL	$58.2 - $72.76 $160,108 - $200,162	-2,751 Reduced 5.67%	45,778 $2.68 Million
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $2.77 Million - $5.76 Million	48,529	48,529 $2.82 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account